九安醫療(002432.SZ):擬以3.4億元投資基金份額 投向醫療健康、信息技術、先進製造、新材料等科技領域
格隆匯9月22日丨九安醫療(002432.SZ)公佈,公司第五屆董事會第二十八次會議審議通過了《關於與專業投資機構共同投資的議案》。同意公司在確保公司主營業務運作正常情況下,以自有資金認購以下投資基金份額,投資金額合計3.4億元人民幣。公司此次參與投資的基金,投資方向主要為醫療健康,以及信息技術、先進製造、新材料等科技領域,均不涉及投資於基建、房地產、影視、娛樂、金融機構持股等情況。公司未來也將圍繞與主業相關的醫療健康,以及科技領域進行佈局。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.